Today, ChemoMetec is listed on the Copenhagen Stock Exchange. ChemoMetec is the ninety-fourth company to join the Nordic Exchange this year.
ChemoMetec develops analytical instruments and techniques in the field of particle analysis. The ChemoMetec technique has been successfully applied in the analysis of biological samples such as yeast cell cultures, blood, animal semen and milk. The company was founded in 1997 and has expanded rapidly since then. ChemoMetec works closely with hospitals, research institutes and universities in order to maintain focus on recent developments and customer needs. Their goal and expertise focuses on the development of high-tech products based on low-cost solutions.
”We are happy to welcome ChemoMetec to the Nordic Exchange’s main market in Copenhagen, where it is this year’s second company within the Healthcare sector. In addition to these two, three new companies within the same sector have been listed on First North in Denmark, which shows that this is an area in rapid development”, says Jan Ovesen, President, OMX Nordic Exchange in Copenhagen.
A round lot of shares in ChemoMetec, whose short name is CHEMM, amounts to 1,000. ChemoMetec is a Small Cap company included in the Healthcare sector.
About OMX | OMX is a leading expert in the exchange industry. Through the Nordic Exchange, OMX offers access to approximately 80 percent of the Nordic and Baltic securities market. The Nordic Exchange is a term used for marketing purposes and is not a legal entity. It describes the common offering from the Helsinki Stock Exchange, Copenhagen Stock Exchange, Stockholm Stock Exchange, Iceland Stock Exchange, Tallinn Stock Exchange, Riga Stock Exchange and Vilnius Stock Exchange. OMX' integrated technology solutions cross the transaction chain enabling efficient securities transactions for over 60 exchange organizations in more than 50 countries. OMX is a Nordic Large Cap company in the Financial sector on the OMX Nordic Exchange. For more information, please visit www.omxgroup.com.
